ZAPATA CORP
10-Q, 1999-08-16
FATS & OILS
Previous: XEROX CORP, 424B3, 1999-08-16
Next: ZENITH NATIONAL INSURANCE CORP, 10-Q, 1999-08-16



<PAGE>   1
                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                    FORM 10-Q

[X]         QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

                  For the quarterly period ended June 30, 1999


                                       OR


[ ]         TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934





                        COMMISSION FILE NUMBER: 001-14003

                               ZAPATA CORPORATION
             (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)


             STATE OF NEVADA                                    C-74-1339132
     (STATE OR OTHER JURISDICTION OF                          (I.R.S. EMPLOYER
     INCORPORATION OR ORGANIZATION)                          IDENTIFICATION NO.)



     100 MERIDIAN CENTRE, SUITE 350
              ROCHESTER, NY                                         14618
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)                         (ZIP CODE)


       REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE: (716) 242-2000


         INDICATE BY CHECK MARK WHETHER THE REGISTRANT (1) HAS FILED ALL REPORTS
REQUIRED TO BE FILED BY SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934 DURING THE PRECEDING 12 MONTHS (OR FOR SUCH SHORTER PERIOD THAT THE
REGISTRANT WAS REQUIRED TO FILE SUCH REPORTS), AND (2) HAS BEEN SUBJECT TO SUCH
FILING REQUIREMENTS FOR THE PAST 90 DAYS.

YES  X  NO    .
    ---    ---

         NUMBER OF SHARES OUTSTANDING (LESS TREASURY SHARES) OF THE REGISTRANT'S
COMMON STOCK, PAR VALUE $0.01 PER SHARE, ON AUGUST 12,1999: 23,887,078
<PAGE>   2
                               ZAPATA CORPORATION
                                TABLE OF CONTENTS


<TABLE>
<S>                                                                                            <C>
PART I.  FINANCIAL INFORMATION

ITEM 1.  FINANCIAL STATEMENTS

         Unaudited Condensed Consolidated Balance Sheets as of June 30, 1999 and
          December 31, 1998...........................................................          3

         Unaudited Condensed Consolidated Statements of Operations for the
           three months and six months ended June 30, 1999 and 1998...................          4

         Unaudited Condensed Consolidated Statements of Cash Flows for the
           three months and six months ended June 30, 1999 and 1998...................          5

         Notes to Unaudited Condensed Consolidated Financial Statements...............          6

ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
           RESULTS OF OPERATION.......................................................         14

PART II. OTHER INFORMATION

ITEM 1.  LEGAL PROCEEDINGS............................................................         25

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K.............................................         26

SIGNATURES............................................................................         27

EXHIBIT INDEX.........................................................................         28
</TABLE>



                                       2
<PAGE>   3
      PART I. FINANCIAL INFORMATION

      ITEM 1. FINANCIAL STATEMENTS AND NOTES

                               ZAPATA CORPORATION

                 UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

                                 (in thousands)


<TABLE>
<CAPTION>
                                                                JUNE 30,     DECEMBER 31,
                                     ASSETS                       1999           1998
                                                               ---------      ---------
<S>                                                            <C>           <C>
Current assets:
      Cash and cash equivalents                                $ 136,939      $ 154,704
      Receivables                                                  7,549          9,811
      Inventories:
          Marine protein products                                 59,271         43,351
      Prepaid expenses and other current assets                    6,591          7,457
                                                               ---------      ---------

             Total current assets                                210,350        215,323
                                                               ---------      ---------

Investments and other assets:
      Production payment receivable                                1,258          1,493
      Other assets                                                17,633         19,105
                                                               ---------      ---------
                                                                  18,891         20,598
                                                               ---------      ---------

Property and equipment, net                                       92,719         86,308

                                                               $ 321,960      $ 322,229
                                                               =========      =========

                      LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
      Current maturities of long-term debt                     $     865      $   1,033
      Accounts payable                                             4,531          2,599
      Accrued liabilities                                         17,675         17,543
                                                               ---------      ---------

            Total current liabilities                             23,071         21,175
                                                               ---------      ---------

Long-term debt                                                    10,832         11,205

Other liabilities                                                 11,526          9,957

Minority interest                                                 63,070         64,800
                                                               ---------      ---------
Commitments and contingencies [Note 4]

Stockholders' equity:
      Common stock                                                   307          7,665
      Capital in excess of par value                             160,750        153,300
      Reinvested earnings, from October 1, 1990                   84,299         85,795
      Treasury stock, at cost                                    (31,668)       (31,668)
      Accumulated other comprehensive income                        (228)            --
                                                               ---------      ---------
            Total stockholders' equity                           213,461        215,092
                                                               ---------      ---------
            Total liabilities and stockholders' equity         $ 321,960      $ 322,229
                                                               =========      =========
</TABLE>

   The accompanying notes are an integral part of the condensed consolidated
                             financial statements.


                                       3
<PAGE>   4
                               ZAPATA CORPORATION

            UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

                    (in thousands, except per share amounts)


<TABLE>
<CAPTION>
                                                                         THREE MONTHS ENDED             SIX MONTHS ENDED
                                                                              JUNE 30,                      JUNE 30,
                                                                      ------------------------      ------------------------
                                                                        1999           1998           1999           1998
                                                                      ---------      ---------      ---------      ---------
<S>                                                                  <C>             <C>           <C>             <C>
Revenues                                                              $  18,225      $  31,488      $  40,387      $  61,529
                                                                      ---------      ---------      ---------      ---------

Expenses:
  Operating                                                              14,532         18,026         29,213         34,161
  Depreciation and amortization                                           2,647          1,024          4,664          2,355
  Selling, general and administrative                                     3,998          3,196          6,831          6,592
                                                                      ---------      ---------      ---------      ---------
                                                                         21,177         22,246         40,708         43,108
                                                                      ---------      ---------      ---------      ---------

Operating (loss) income                                                  (2,952)         9,242           (321)        18,421
                                                                      ---------      ---------      ---------      ---------

Other income (expense):
  Interest income (expense), net                                          1,412          2,458          3,074          2,738
  Equity in (loss) of unconsolidated affiliates                              --         (4,116)            --         (3,248)
  Gain on sale of Omega Protein                                              --         86,662             --         86,662
  Other (expense), net                                                     (120)           (56)        (3,508)          (121)
                                                                      ---------      ---------      ---------      ---------
                                                                          1,292         84,948           (434)        86,031
                                                                      ---------      ---------      ---------      ---------

Income (loss) before income taxes and minority interest                  (1,660)        94,190           (755)       104,452
                                                                      ---------      ---------      ---------      ---------

Provision for (benefit from) income taxes                                  (564)        31,721           (257)        35,513
Minority interest in net (loss) income of consolidated subsidiary          (211)         4,329            998          4,329
                                                                      ---------      ---------      ---------      ---------

Net (loss) income                                                    $     (885)     $  58,140     $   (1,496)     $  64,610
                                                                      =========      =========      =========      =========
Other comprehensive income, net of tax:
  Unrealized (loss) on securities                                          (228)            --           (228)            --
                                                                      ---------      ---------      ---------      ---------
Comprehensive income                                                     (1,113)        58,140         (1,724)        64,610
                                                                      =========      =========      =========      =========

Per share data (basic):
    Net (loss) income per share (basic)                              $    (0.04)     $    2.52     $    (0.06)     $    2.82
                                                                      =========      =========      =========      =========

Average common shares outstanding                                        23,887         23,117         23,887         22,930
                                                                      =========      =========      =========      =========

Per share data (diluted):
    Net (loss) income per share (diluted)                            $    (0.04)     $    2.40     $    (0.06)     $    2.67
                                                                      =========      =========      =========      =========

Average common shares and common share equivalents
    outstanding                                                          23,887         24,229         23,887         24,180
                                                                      =========      =========      =========      =========
</TABLE>

   The accompanying notes are an integral part of the condensed consolidated
                             financial statements.

                                       4
<PAGE>   5
                                 ZAPATA CORPORATION

                  UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

                                   (in thousands)


<TABLE>
<CAPTION>
                                                                            SIX MONTHS ENDED
                                                                                JUNE 30,
                                                                          1999           1998
                                                                        ---------      ---------
<S>                                                                    <C>             <C>
Cash flows provided (used) by operating activities:
    Net (loss) income                                                   $  (1,496)     $  68,939
                                                                        ---------      ---------
    Adjustments to reconcile net income to net cash provided (used)
       by operating activities:
         Depreciation and amortization                                      4,664          2,355
         Gain on sale of Omega Protein and other assets                        --        (86,835)
         Equity in loss of unconsolidated affiliates                           --          3,248
         Minority interest in net income of consolidated subsidiary           998          4,329
         Changes in assets and liabilities
            Receivables                                                     2,262         (4,399)
            Inventories                                                   (15,920)        (7,710)
            Prepaid expenses and other current assets                         640            407
            Accounts payable and accrued liabilities                        2,064          4,943
            Other assets and liabilities                                    2,348         12,048
                                                                        ---------      ---------
                 Total adjustments                                         (2,945)       (71,614)
                                                                        ---------      ---------
             Net cash used by operating activities                         (4,441)        (2,675)
                                                                        ---------      ---------

Cash flows provided (used) by investing activities:
    Proceeds from sale of fixed assets, net                                    --            460
    Proceeds from production payment receivable                               235            184
    Capital additions                                                     (11,075)       (12,442)
                                                                        ---------      ---------
               Net cash used by investing activities                      (10,840)       (11,798)
                                                                        ---------      ---------

Cash flows provided (used) by financing activities:
    Proceeds from issuance of Omega Protein common stock                       --        144,543
    Proceeds from borrowing -Bank debt                                         --          3,331
    Proceeds from exercise of stock options                                    92            776
    Purchase of treasury shares by consolidated subsidiary                 (2,035)            --
    Purchase of treasury stock                                                 --         (1,497)
    Repayments of long-term obligations                                      (541)        (2,595)
    Dividends paid                                                             --         (3,216)

                                                                        ---------      ---------
              Net cash (used) provided by financing activities             (2,484)       141,342
                                                                        ---------      ---------

Net (decrease) increase in cash and cash equivalents                      (17,765)       126,869
Cash and cash equivalents at beginning of period                          154,704         32,384
                                                                        ---------      ---------
Cash and cash equivalents at end of period                              $ 136,939      $ 159,253
                                                                        =========      =========

</TABLE>

          The accompanying notes are an integral part of the condensed
consolidated financial statements.

                                       5
<PAGE>   6
                               ZAPATA CORPORATION
         NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1. FINANCIAL STATEMENTS

         SUMMARY OF OPERATIONS AND BASIS OF PRESENTATION

         Zapata Corporation ("Zapata" or the "Company") is the holder of
approximately 61% of the outstanding common stock of Omega Protein Corporation,
("Omega Protein,") (formerly known as Marine Genetics Corporation and Zapata
Protein Corporation) (NYSE: OME) which markets a variety of products produced
from menhaden (a fish found in commercial quantities), including regular grade
and value added specialty fish meals, crude and refined fish oils and fish
solubles. Zapata also holds approximately 40% of the outstanding common stock of
Viskase Companies, Inc. ("Viskase") (formerly known as Envirodyne Industries,
Inc.) (Nasdaq: VCIC) which is primarily engaged in the business of selling food
packaging products and disposable food service supplies. Zapata also operates
the Internet based magazines Word and Charged and its Internet subsidiary
ZAP.COM Corporation ("ZAP.COM").

         On December 21, 1998, the Company's Board of Directors approved a
change in the Company's fiscal year end from September 30 to December 31, which
became effective January 1, 1999. The December 31, 1998 balances used throughout
this report were derived from the Quarterly Report on Form 10-Q for the
transition period ending December 31, 1998 filed with the Securities and
Exchange Commission by Zapata on February 14, 1999. The condensed consolidated
balance sheets at June 30, 1999 and December 31, 1998 have been derived from the
unaudited financial statements at those dates.

         On April 13, 1999, the Company's stockholders approved the
reincorporation of the Company as a Nevada corporation and a related Agreement
and Plan of Merger. On April 30, 1999, the Company effected the merger by
merging into a wholly-owned Nevada subsidiary. In connection with the
reincorporation, the par value of the Company's common stock was changed from
$.25 per share to $.01 per share. The change in the par value was effectuated by
a reclassification between the common stock, at par value and capital in excess
of par, respectively, on the balance sheet.

         The unaudited condensed consolidated financial statements included
herein have been prepared by the Company, without audit, pursuant to the rules
and regulations of the Securities and Exchange Commission (the "Commission").
The financial statements reflect all adjustments that are, in the opinion of
management, necessary to fairly present such information. All such adjustments
are of a normal recurring nature. Although Zapata believes that the disclosures
are adequate to make the information presented not misleading, certain
information and footnote disclosures, including a description of significant
accounting policies normally included in financial statements prepared in
accordance with generally accepted accounting principles, have been condensed or
omitted pursuant to such rules and regulations. These condensed financial
statements should be read in conjunction with the financial statements and the
notes thereto included in Zapata's latest Annual Report on Form 10-K filed with
the Securities and Exchange Commission. The results


                                       6
<PAGE>   7
of operations for the fiscal period from January 1, 1999 to June 30, 1999 are
not necessarily indicative of the results for any subsequent quarter or the
entire fiscal year ending December 31, 1999.

Use of estimates

         The preparation of financial statements in conformity with generally
accepted accounting principles requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities at the
date of the financial statements and the reported amounts of revenues and
expenses during the reporting period. Actual results could differ from those
estimates.

Reclassification

         For the period ending June 30, 1999, reclassification of prior period
information has been made to conform with the current year presentation. These
reclassifications had no effect on net income or stockholders' equity reported
for prior periods.

Comprehensive income

         Accumulated other comprehensive income consists of unrealized gains on
available-for-sale securities (theglobe.com,inc.), net of tax as presented on
the accompanying condensed consolidated balance sheets.


Omega Protein initial public offering

         On April 8, 1998, the Company's then wholly-owned subsidiary, Omega
Protein, completed an initial public offering of 8,500,000 shares of its common
stock at a gross price of $16 per share. On May 7, 1998, the Underwriters
exercised their option to acquire 1,275,000 additional shares at the same gross
price (the entire transaction being referred to as the "Offering"). Of the
9,775,000 total shares sold in the Offering, Zapata sold 5,175,000 shares and
Omega Protein issued and sold 4,600,000 shares.

         In connection with the Offering, Zapata received $76.6 million from the
sale of its 5,175,000 shares of Omega Protein common stock after deducting
commissions and selling expenses of $6.2 million. Additionally, Omega Protein
received $68.0 million from the sale of 4,600,000 shares of its common stock
after deducting commissions and offering expenses. Omega Protein used a portion
of its net proceeds to repay approximately $33.3 million of inter-company
indebtedness owed to Zapata. As a result of the Offering, Zapata recorded an
$86.7 million gain and related tax effects of $31.4 million or $2.31 per share
(diluted).

NOTE 2.  ACQUISITIONS

         On November 3, 1997, Omega Protein acquired the fishing and processing
assets of


                                       7
<PAGE>   8
American Protein, Inc. ("American Protein"), which operated ten fishing vessels
and a menhaden processing plant in the Chesapeake Bay area, for $14.5 million in
cash (the "American Protein Acquisition").

         On November 25, 1997, Omega Protein purchased the fishing and
processing assets of Gulf Protein, Inc. ("Gulf Protein"), which included six
fishing vessels, five spotter planes and the processing equipment located at the
Gulf Protein plant near Morgan City, Louisiana for $13.6 million in cash and the
assumption of $883,000 in liabilities (the "Gulf Protein Acquisition" together
with the "American Protein Acquisition" the "Acquisitions").

         The Acquisitions were financed by a $28.1 million inter-company loan
from Zapata. Interest on this loan was accrued at a rate of 8.5 % per annum and
was repayable in quarterly installments beginning May 1, 1998. The loan, which
was to mature on August 1, 2002, was prepaid in May 1998 with a portion of the
proceeds from Omega Protein's initial public offering.

         On April 27, 1998, the Company acquired from ICON CMT Corporation
(which was subsequently acquired by Qwest Communications Corporation) ("Qwest"),
the assets used in connection with the operation of the Word and Charged on-line
Web magazines in consideration for the assumption of certain related liabilities
and obligations and nominal cash consideration. In connection with the
acquisition, the Company and ICON CMT entered into a multi-year services
agreement obligating the Company to purchase a minimum of $2 million in services
over four years.

NOTE 3.  UNCONSOLIDATED AFFILIATES

         Zapata reports its equity in Viskase's results of operations on a
three-month delayed basis since Viskase's financial statements are not available
to the Company on a basis that would permit concurrent reporting. In Viskase's
Quarterly Report on Form 10-Q for the quarter ended September 24, 1998, Viskase
reported it had incurred a net loss of $119.6 million, including unusual charges
of $148.6 million in connection with the restructuring of its worldwide
operations and net write-down of excess reorganization value. The charge was
primarily non-cash in nature, and included $6.0 million for cash severance and
decommissioning and certain non-cash charges, $40.1 million for Chicago plant
write-offs, $3.0 million for inventory and maintenance store charges, $8.3
million for the shutdown of certain foreign operations and $91.2 million for the
write-down of the corporations reorganization value.

         Because Zapata has not guaranteed any obligations and is not committed
to provide any financial support to Viskase, Zapata only recorded its equity in
Viskase's loss for Viskase's quarter ended September 24, 1998 to the extent that
it reduced Zapata's net investment in Viskase to zero. Zapata will resume
recording its equity in Viskase's earnings when its share of Viskase's net
income equals the share of net losses not recognized during the period the
equity method was suspended.

         The financial statement information presented below for Viskase is
based upon its March 31, 1999 quarterly results. As discussed above, Zapata will
not recognize equity in the


                                       8
<PAGE>   9
performance of Viskase until its total equity in Viskase, (including its share
of losses not recognized during the period the equity method was suspended) is
greater than zero. Accordingly, Zapata did not recognize any equity in the
performance of Viskase during Zapata's quarter ending June 30, 1999. The
financial performance of Viskase during its quarter ending March 31, 1999 is
summarized below (in millions, except per share amounts):



                             VISKASE COMPANIES, INC.
                                   (Unaudited)

<TABLE>
<CAPTION>
                                                                           MARCH 31,
                                                                              1999
                                                                              ----
<S>                                                                        <C>
         BALANCE SHEET
         Current assets ..............................................     $   175.1
         Other assets ................................................          34.8
         Property and equipment, net .................................         321.8
                                                                           ---------
                  Total assets .......................................     $   531.7
                                                                           =========

         Current liabilities .........................................     $   125.1
         Long-term debt ..............................................         404.0
         Deferred income taxes and other .............................          71.4
         Stockholders' equity ........................................         (68.8)
                                                                           ---------
                  Total liabilities and stockholders' equity .........     $   531.7
                                                                           =========
</TABLE>


<TABLE>
<CAPTION>
                                                                      THREE MONTHS
                                                                         ENDED
                                                                       MARCH 31,
                                                                         1999
                                                                         ----
<S>                                                                   <C>
         INCOME STATEMENT
         Revenues ................................................     $   92.1
                                                                       ========

         (Loss) before income taxes ..............................     $  (12.2)
                                                                       ========

         Net (loss) ..............................................     $  (11.3)
                                                                       ========

         Net (loss) per share ....................................     $  (0.76)
                                                                       ========

         Comprehensive loss ......................................     $  (12.3)
                                                                       ========
</TABLE>


NOTE 4. COMMITMENTS AND CONTINGENCIES

         On August 11, 1995, a derivative and class action was filed by Elly
Harwin against the Company and its then directors in the Court of Chancery of
the State of Delaware, New Castle County. On January 18, 1996, a second
derivative action was filed by Crandon Capital Partners against the Company and
its directors in the same court. On May 7, 1996, a third derivative action was
filed by Elly Harwin and Crandon Capital Partners against the Company and its
directors in the same court. These cases have since been consolidated into one
case (the "Harwin/Crandon Case"), by way of an amended, consolidated
complaint (the "Harwin/Crandon Complaint"). On April 29, 1999, the parties to
this action entered into a stipulation pursuant to


                                       9
<PAGE>   10
which the Harwin/Crandon Complaint has been dismissed without prejudice, subject
to Court approval. For additional information concerning this litigation and
other legal proceedings, see Item 3 of the Company Annual Report on Form 10-K
for the fiscal year ended September 30, 1998.

         On April 30, 1999, a state district court in Houston, Texas entered a
judgment against Zapata in a lawsuit brought by a former employee which was
commenced on April 1, 1998. The former employee alleged that he was entitled to
the value of options for approximately 240,000 shares of Zapata stock which he
alleges should have been issued to him in 1998 pursuant to his employment
agreement with Zapata. The judgment against Zapata was for approximately $3.45
million, which includes prejudgment interest. Zapata has posted a bond and
appealed the judgement. The Company continues to believe that it has a
meritorious defense to all or a substantial portion of the plaintiff's claim.
However, there can be no assurance that the Company will be successful in
appealing the judgment.

         On November 9, 1995, a petition was filed in the 148th Judicial
District of Nueces County, Texas by Peter M. Holt, a former director of the
Company, and certain of his affiliates who sold their interests in Energy
Industries, Inc. and other natural gas compression companies ("Energy
Industries") to the Company in November 1993 (the "Holt Case"). Effective March
10, 1999 the Company entered into a settlement agreement which settled all
claims in the Holt Case. The Settlement Agreement, the terms of which are
confidential, provided for the dismissal of all of claims by the parties and the
execution of mutual release and certain payments by the Company. The settlement
did not have a material adverse effect on either the Company's financial
position or results of operations.

         Between October 21, 1998 and December 4, 1998, 20 essentially
identical, purported securities class action lawsuits were filed against the
Company and certain of its current and former officers and directors. All of the
suits were filed in United States District Court for the Southern District of
Texas, Houston Division, which generally allege that the Company and current and
former members of its management violated Sections 10(a) and 20(a) of the
Securities Exchange Act of 1934 by making false and misleading statements
concerning the Company's business condition, strategy and future business
prospects with respect to various internet acquisitions, which allegedly
artificially inflated the price of the Company's common stock. The putative
class actions were commenced on behalf of persons who purchased the Company's
common stock between July 6, 1998 through October 15, 1998. The plaintiffs seek
unspecified monetary damages and their costs and expenses incurred in the
actions. On January 6, 1999, the District Court entered an order consolidating
the securities class action litigation into a single action entitled In re
Zapata Corporation Securities Litigation, H-98-3498, and on January 19, 1999,
entered an order appointing lead plaintiffs and approving lead plaintiffs'
selection of co-lead counsel. On February 16, 1999, plaintiffs filed a
consolidated amended complaint in the District Court. The defendants filed a
motion to dismiss to the amended consolidated complaint on April 2, 1999. The
Company believes this lawsuit is without merit and intends to defend it
vigorously. However, this lawsuit is in its early stages and there can be no
assurances that this litigation will ultimately be resolved on terms that are
favorable to the Company.



                                       10
<PAGE>   11
         On August 17, 1998, LFG, Inc. d/b/a Zap Futures ("LFG") commenced an
action against Zapata and its wholly-owned subsidiary, Zap Corporation in the
United States District Court for the Northern District of Illinois. On or about
April 5, 1999, the parties reached an agreement in principle pursuant to which
they agreed to settle this action on a confidential basis. The parties are
currently negotiating the definitive settlement agreements. The Company does not
anticipate that the terms of the settlement will have a material adverse affect
on the Company's financial condition or results. For additional information
concerning this litigation and other legal proceedings, see Item 3 of the
Company's Annual Report on Form 10-K for the fiscal year ended September 30,
1998.

         From time to time, the Company is involved in litigation relating to
claims arising out of its operations in the normal course of its business. The
Company maintains insurance coverage against such potential ordinary course
claims in an amount which it believes to be adequate. While the results of any
ultimate resolution can not be predicted, in the opinion of the Company's
management, based on discussion with counsel, except for the matters described
above, the likelihood of uninsured losses having a material adverse effect on
Zapata's results of operations, cash flows or financial position is remote.

NOTE 5.  TRANSACTIONS AND ARRANGEMENTS BETWEEN THE COMPANY AND ITS AFFILIATES

         Omega Protein provides to Zapata payroll and certain administrative
services billed at their approximate cost. During the six-month periods ended
June 30, 1999 and June 30, 1998 fees for these services totaled approximately
$97,000 and $76,000, respectively. The cost of such services were based on the
estimated percentage of time that employees spent working on the other party's
matters as a percent of total time worked. The Company's management deemed this
allocation method to be reasonable.

         Upon completion of Omega Protein's initial public offering in April
1998, the Company entered into certain agreements with Omega Protein that
include the Separation, Sublease, Registration Rights, Tax Indemnity and
Administrative Services Agreements. The Separation Agreement required Omega
Protein to repay $33.3 million of indebtedness owed to Zapata contemporaneously
with the consummation of the Omega Protein's initial public offering and also
prohibits Zapata from competing with Omega Protein for a period of five years.
The Sublease Agreement provides for Omega Protein to lease its principal
corporate offices in Houston, Texas from Zapata and provides for Omega Protein
to utilize certain shared office equipment for no additional charge. The
Registration Rights Agreement sets forth the rights and


                                       11
<PAGE>   12
responsibilities of each party concerning certain registration filings and
provides for the sharing of fees and expenses related to such filings. The Tax
Indemnity Agreement requires Omega Protein to be responsible for federal, state
and local income taxes from its operations and the Administrative Services
Agreement allows Omega Protein to provide certain administrative services to
Zapata at Omega Protein's estimated cost.

         Pursuant to the ZAP.COM Rights Offering, ZAP.COM has satisfied its
startup and offering costs with borrowings from Zapata. Through June 30, 1999,
ZAP.COM has incurred approximately $500,000 in start-up costs that have been
expensed as incurred along with approximately $122,000 in offering costs that
are being deferred to be applied against the proceeds of the Rights Offering.
ZAP.COM anticipates to incur additional offering costs associated with the
Rights Offering of approximately $730,000. Zapata will satisfy these and future
payments. If the Rights Offering is not completed, Zapata has agreed to forgive
this debt.

NOTE 6. COMPREHENSIVE INCOME

         Accumulated other comprehensive income at June 30, 1999 consists of
unrealized loss on available-for-sale securities of approximately $350,000, net
of estimated tax benefit of $122,500. There were no components of comprehensive
income at December 31, 1998.


NOTE 7. MINORITY INTEREST

         During the six months ended June 30, 1999, Omega Protein made
cumulative purchases of 413,100 shares of its common stock on the open market
for a total of approximately $2.0 million. Zapata accounts for its investment in
Omega Protein under the consolidation method. Accordingly, Zapata reduced the
minority interest in Omega Protein on its balance sheet by the value of the
treasury stock purchased by Omega Protein. In addition, these treasury shares
were purchased by Omega Protein at a cost that was below Zapata's book value in
its Omega Protein shares. As a result, Zapata has recorded a valuation allowance
that reduced the value of its long-term assets to reflect the total discount to
book value of the acquired shares.

NOTE 8.  ZAP.COM CORPORATION RIGHTS OFFERING

         On April 13, 1999, Zapata's wholly-owned subsidiary, ZAP.COM, filed a
registration statement on Form S-1, (the "Registration Statement") with the
Commission for the purpose of effecting a rights offering of ZAP.COM common
stock to be directed to Zapata's stockholders, which would in effect be an
initial public offering (the "Rights Offering") by ZAP.COM. Each Zapata
stockholder will receive one right for the purchase of one share of ZAP.COM
common stock as of the applicable record date. The Rights Offering is expected
to be for up to 13,612,000 shares of common stock, par value $.001 per share,
of ZAP.COM ("ZAP.COM Common Stock"). In the Registration Statement, ZAP.COM
used an assumed exercise price for the rights of $8.00 per share. Malcolm
Glazer and Avram Glazer have informed ZAP.COM that they intend to exercise
135,306 rights for an aggregate exercise price of $1,082,448. Accordingly, the
Glazers will not be distributed the balance of the rights they would otherwise
be entitled to receive. In connection with the Rights Offering, Zapata will
invest $8 million in ZAP.COM in exchange for 10,000 shares of ZAP.COM Series A
preferred stock and 70,000 shares of Series B preferred stock. It is expected
that ZAP.COM will have between 50,135,306 and 63,612,000 shares of common stock
outstanding following the Rights Offering. Zapata will have no obligation to
make additional investments in or funding available to ZAP.COM, though it may
elect to offer such financing to ZAP.COM in the future. If insufficient rights
are exercised for ZAP.COM to meet certain requirements of the NASDAQ National
Market. Zapata intends


                                       12
<PAGE>   13
to distribute to its stockholders, on a pro rata basis, between 150,000 and
3,000,000 shares of ZAP.COM Common Stock. Following completion of the Rights
Offering as presently contemplated, Zapata would own between approximately 79%
and 94% of the outstanding ZAP.COM Common Stock depending upon the number of
rights that are exercised. The Rights Offering is expected to be completed in
the third or fourth quarter of fiscal 1999. However, as the date hereof, no
assurance can be given that the Rights Offering will be completed or, if
completed, will be completed on the terms, including the assumed exercise price
for the rights to purchase ZAP.COM Common Stock described in this report.

        As of and prior to June 30, 1999, ZAP.COM has satisfied all of its
startup and offering costs with borrowings from Zapata. ZAP.COM has agreed to
settle the amounts due to Zapata with the proceeds available, if any, to
ZAP.COM immediately following the Rights Offering. If the offering is not
completed, Zapata has agreed to forgive this debt.

                                       13
<PAGE>   14
ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
         OF OPERATIONS

         Forward-looking statements in this Form 10-Q, future filings by the
Company with the Securities and Exchange Commission ("Commission"), the
Company's press releases and oral statements by authorized officers of the
Company are intended to be subject to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Investors are cautioned that all
forward-looking statements involve risks and uncertainty, including without
limitation those identified from time to time in press releases and other
communications with stockholders by the Company and the filings made with the
Securities and Exchange Commission by the Company, Omega Protein Corporation
("Omega Protein" or "Omega") and Viskase Companies, Inc., ("Viskase"), including
those disclosed under the caption "Significant Factors That Could Affect Future
Performance and Forward-Looking Statements" appearing in Item 2 "Management's
Discussion and Analysis of Financial Condition and Results of Operation" of the
Company's Annual Report on Form 10-K for the fiscal year ended September 30,
1998 filed with the Commission. The Company believes that forward-looking
statements made by it are based on reasonable expectations. However, no
assurances can be given that actual results will not differ materially from
those contained in such forward-looking statements. The words "estimate,"
"project," "anticipate," "expect," "predict," "believe" and similar expressions
as well as the Company's statements concerning the state of the Company's Year
2000 readiness and the ZAP.COM Rights Offering described herein are intended to
identify forward-looking statements. The Company assumes no obligation to
upgrade forward-looking statements.

GENERAL

         On April 8, 1998, Omega Protein completed its initial public offering
of 8,500,000 shares of its common stock at a gross price of $16 per share (the
"Omega Protein Offering"). On May 7, 1998, the underwriters exercised their
over-allotment option to acquire 1,275,000 additional shares at the same gross
price (the "Omega Protein Offering"). Of the 9,775,000 shares sold in the Omega
Protein Offering, Zapata sold 5,175,000 shares and Omega Protein issued and sold
4,600,000 shares. Immediately following the Omega Protein Offering, Zapata owned
59.7% of Omega Protein's outstanding common stock. Since the Omega Protein
Offering, Zapata has reported Omega Proteins' results of operations on a
consolidated basis eliminating all inter-company transactions and recording a
minority interest. In connection with the Omega Protein Offering, Zapata
received $76.6 million from the sale of Omega Protein shares after deducting
commissions and selling expenses. Additionally, Omega Protein received $68.0
million from the issuance of shares after deducting commissions and offering
expenses. Omega Protein used a portion of its net proceeds to repay
approximately $33.3 million of inter-company indebtedness and $2.1 million in
bank debt. Pending use, Zapata and Omega Protein has invested the net proceeds
in government securities and high quality commercial paper graded A2P2 or
better. As a result of the Omega Protein Offering, Zapata recorded a gain net of
taxes of $55.3 million or $2.31 per share (diluted).

         Zapata currently owns approximately 40% of the outstanding shares of
Viskase common


                                       14
<PAGE>   15
stock. In Viskase's Quarterly Report on Form 10-Q for the quarter ended
September 24, 1998, Viskase reported it had incurred a net loss of $119.6
million, including unusual charges of $148.6 million in connection with the
restructuring of its worldwide operations and net write-down of excess
reorganization value. Because Zapata has not guaranteed any obligations and is
not committed to provide any financial support to Viskase, Zapata only recorded
its equity in Viskase's loss for Viskase's quarter ended September 24, 1998 to
the extent that it reduced Zapata's net investment in Viskase to zero. As a
result, Zapata recognized a loss of $11.8 million on its Viskase investment
during the three months ended December 31, 1998. Zapata will resume recording
its equity in Viskase's earnings when its share of Viskase's net income equals
the share of net losses not recognized during the period the equity method was
suspended. [See "Part I - Financial Statements Note 3.-Unconsolidated
Affiliates"]

         On December 21, 1998, the Company's Board of Directors approved a
change in the Company's fiscal year from September 30 to December 31, which
became effective January 1, 1999.

         On April 13, 1999 and as amended on July 2, 1999, Zapata's wholly-owned
subsidiary ZAP.COM Corporation ("ZAP.COM"), a Nevada Corporation, which is a
development stage company filed a registration statement on Form S-1 with the
Securities and Exchange Commission for the purpose of conducting a rights
offering. The Rights Offering will be directed to Zapata's stockholders and is
expected to entitle Zapata's stockholders to purchase one share of ZAP.COM
common stock at a purchase price of $8.00 per share for every one share of
Zapata common stock they own. ZAP.COM is seeking to raise up to $108.9 million
through the rights offering of up to 13.612 million shares of ZAP.COM common
stock. Zapata will retain a majority ownership of ZAP.COM immediately following
the Rights Offering, and will account for ZAP.COM as a consolidated subsidiary.
As of August 10, 1999, the registration statement has not been declared
effective, and a record date for the Rights Offering had not been set. The
Rights Offering is expected to be completed in the third or fourth quarter of
fiscal 1999. However, as the date hereof, no assurance can be given that the
Rights Offering will be completed or, if completed, that it will be completed
on the terms, including the assumed exercise price for the rights to purchase
ZAP.COM Common Stock, described in this report. For further information on the
Rights Offering See Part I -"Condensed Consolidated Financial Statements
Note 8. -ZAP.COM Corporation Rights Offering." Also, see those factors listed
under the caption "Risk Factors" contained in ZAP.COM's registration statement
in Form S-1/A filed with the Securities and Exchange Commission on July 2, 1999.

ZAPATA CORPORATION CONSOLIDATED LIQUIDITY AND CAPITAL RESOURCES

         Prior to the Omega Protein Offering, Zapata, as the sole stockholder of
Omega Protein caused cash to be moved between the Company and Omega Protein as
each company had cash needs. As a result of the Omega Protein Offering, Zapata
and Omega Protein are now separate public companies and each entity's capital
resources and cash flows are legally independent of the other in the absence of
cash dividends. The assets of Omega Protein are now dedicated to its operations
and are not expected to be readily available for the general corporate purposes
of Zapata. Accordingly, following the Omega Protein Offering and until the
Company acquires


                                       15
<PAGE>   16
another operating company, it's primary sources of additional cash will include
existing cash and cash equivalent balances, sales of equity securities, interest
earned on cash equivalents and dividends earned on equity securities. For the
foreseeable future, the Company does not expect to receive cash dividends on its
holdings of Omega Protein common stock or Viskase common stock.

         Zapata's consolidated working capital totaled $187.3 million and $194.1
million as of June 30, 1999 and December 31, 1998, respectively. Substantially
all of the Company's consolidated cash and cash equivalent balances of $136.9
million (including $32.9 held by Omega Protein) as of June 30, 1999 were
deposited with four major banking institutions in interest-bearing accounts or
invested in high grade commercial paper rated A2P2 or better.

         Zapata's consolidated cash balance totaled $136.9 million at June 30,
1999, down from $154.7 million at December 31, 1998. The decrease was due
primarily to Omega Protein's capital expenditures for equipment and equipment
replacements, a build-up in Omega Protein's inventory, the purchase of treasury
stock by Omega Protein, Zapata's settlement of the Holt litigation, and the use
of funds to support Zapata's operating activities, including its Internet
properties Word, Charged and ZAP.COM.

         Cash used by operating activities was $4.4 million for the six months
ended June 30, 1999 versus a use of $2.7 million in the corresponding period
ending June 30, 1998. The June 30, 1999 results primarily reflected the impact
of Omega Protein's build-up of its fishmeal inventory due to unfavorable
commodity pricing of menhaden oil during the period.

         Primarily reflecting capital expenditures by Omega Protein investing
activities used $10.8 million and $11.8 million during the six months ending
June 30, 1999 and June 30, 1998, respectively. These expenditures were made by
Omega Protein to continue improvement and upgrading to its production
facilities.

         Financing activities used approximately $2.5 million during the six
months ended June 30, 1999 which consisted of repayment of debt by Omega Protein
and approximately $2.0 million used by Omega to repurchase approximately 413,000
of its stock. Financing activities provided $141.3 million in the first six
months of 1998 which was the result of the Omega Protein initial public
offering, offset by repayments of debt and the payment of dividends. As part of
the ZAP.COM Rights Offering, Zapata anticipates investing $8 million of equity
in ZAP.COM during the third or fourth quarter of the current fiscal year.

         On July 6, 1998, Zapata's Board of Directors approved a stock
repurchase program allowing Zapata to repurchase up to five million shares of
its common stock. No time limit has been placed on the duration of the program
and no minimum number of shares to be repurchased has been fixed. Subject to
applicable securities laws, shares may be repurchased from time to time in the
open market or private transactions. Purchases are subject to availability of
shares at prices deemed by Zapata's management and other corporate
considerations. Repurchased shares will be held as treasury shares available for
general corporate purposes. As of August 12, 1999, Zapata had not repurchased
any shares pursuant to such authorization. To the extent that shares


                                       16
<PAGE>   17
are repurchased under the program, Zapata's liquidity and working capital will
be correspondingly reduced. Zapata's liquidity and working capital could also be
significantly affected by additional capital commitments in connection with its
Internet initiative or other acquisition or business opportunities.

         In the absence of unanticipated circumstances, Zapata believes that
existing cash and cash equivalents will be sufficient to meet Zapata's
requirements (including any purchases made by Zapata pursuant to its current
stock repurchase program) at least through the end of 2000.

OMEGA PROTEIN CORPORATION LIQUIDITY AND CAPITAL RESOURCES

         Omega Protein's primary sources of liquidity and capital resources have
     been cash flows from operations, proceeds from initial public offering,
     pre-initial public offering borrowings from Zapata, bank credit facilities
     and term loans from various lenders provided pursuant to the Title XI of
     the Marine Act of 1936 ("Title XI"). These sources of cash flows have been
     used for capital expenditures (including acquisitions) and payment of
     long-term debt. Omega Protein expects to finance future expenditures
     through existing cash balances, internally generated cash flows and, if
     necessary, through funds available from its $20.0 million credit facility
     and/or Title XI facilities described below.

         Under the Title XI program offered through National Marine Fisheries
     Service, Omega has the ability to secure loans for fishing vessels and
     shoreside capital expenditures and maintenance through lenders with terms
     generally ranging between 12 and 20 years at an interest rate between 6%
     and 8% per annum which are enhanced with a government guaranty to the
     lender for up to 80% of the financing. Omega's current Title XI borrowings
     are secured by liens on 14 fishing vessels and mortgages on its Reedville,
     Virginia and Abbeville, Louisiana plants. Omega is currently authorized to
     receive up to $20.6 million in loans under this program. To date, Omega has
     used $15.0 million of these funds and is currently negotiating to utilize
     the remaining $5.6 million available from this program.

         On September 17, 1998 Omega's Board of Directors authorized the
     repurchase of up to 4.0 million shares of its common stock from time to
     time, depending on market conditions. No time limit has been placed on the
     duration of the program and no minimum number or value of shares to be
     repurchased has been fixed. Subject to applicable securities laws, shares
     may be repurchased from time to time in the open market or private
     transactions. Purchases are subject to availability of shares at prices
     deemed appropriate by Omega's management and other corporate
     considerations. Repurchased shares will be held as treasury shares
     available for general corporate purposes. During the six-months ended June
     30, 1999, Omega repurchased 413,100 shares for a total cost of $2.0 million
     or an average cost of $4.84 per share. To the extent that additional shares
     are repurchased under the program Omega's liquidity and working capital
     will be correspondingly reduced.

         Omega had an unrestricted cash balance of $32.9 million at June 30,
     1999, down $11.9 million from December 31, 1998. This decrease was due to
     $12.8 million increase in cash used in investing and financing activities,
     offset by $0.8 million in cash provided by


                                       17
<PAGE>   18
     operations.

         Investing activities used $10.2 million in the six-months ended June
     30, 1999 and $12.7 million during the six-months ended June 30, 1998.
     Omega's investing activities consisted mainly of capital expenditures for
     equipment purchases and equipment replacements in the six-month periods
     ended June 30, 1999 and 1998.

         Net financing activities used $505,000 to repay debt obligations and
     $2.0 million to repurchase stock during the six-month period ended June 30,
     1999 compared with $39.9 million cash provided by net financing activities
     during the six month period ended June 30, 1998 due primarily to Omega's
     completed public offering on April 8, 1998.

         Omega has reported that it believes that its existing cash, cash
     equivalents, short-term investments and funds available through its credit
     facility will be sufficient to meet its working capital and capital
     expenditure requirements through at least the end of 2000.

ZAPATA CORPORATION CONSOLIDATED RESULTS OF OPERATIONS

FISCAL QUARTER ENDED JUNE 30, 1999

         Zapata had a consolidated net loss of approximately $885,000 for the
quarter ending June 30, 1999 compared to net income of $58.1 million for the
quarter ending June 30, 1998. The June 30, 1998 quarter includes Zapata's $86.7
million gain recognized by Zapata in connection with Omega Protein's initial
public offering. The loss was primarily attributable to a decline Omega
Protein's revenue during the quarter caused by unfavorable pricing conditions in
world protein markets. The June 30, 1998 quarter results reflected favorable
operating results of Omega Protein and Zapata's gain on the sale of Omega
Protein common stock. Revenues totaled $18.2 million during the 1999 quarter
versus $31.5 million during the 1998 quarter, almost all of which are
attributable to Omega Protein, Omega Protein's revenues were adversely affected
by a general softening of the protein and oil commodities markets. The Company
experienced an operating loss during the quarter ended June 30, 1999 as lower
Omega Protein operating costs could not fully offset the decline in revenues
experienced by Omega Protein. In addition, operating cost increased at Zapata
due to costs related to the operations of its two webzines, Word and Charged,
and the proposed ZAP.COM rights offering. The Company anticipates incurring
significant operating expenses during the remainder of this year and next year
in connection with the consolidation of ZAP.COM into its financial statements.

         The Company's net interest income was lower in the current period as
compared to the corresponding prior-year period reflecting lower levels of cash.
In the prior year quarter, the Company realized an $86.7 million gain on the
sale of a portion of its shares in Omega Protein and recorded an equity loss on
its investment of its unconsolidated subsidiary, Viskase. The Company also
recorded a tax benefit of $564,000 for the quarter ending June 30, 1999 which
represents an effective tax rate of 34% on losses prior to consideration of
minority interests. The effective tax rate approximates the applicable combined
state and federal statutory tax rates for the fiscal year. Minority interest
recorded in the 1999 quarter represents the


                                       18
<PAGE>   19
approximately 40% ownership interest of Omega Protein not owned by Zapata.

SIX MONTHS ENDED JUNE 30, 1999

         For the first six months of fiscal 1999, Zapata reported revenues of
$40.4 million and a net loss of $1.5 million compared to revenues of $61.5
million and net income of $68.9 million in the comparative 1998 period. The 1999
results primarily reflect Omega Protein's decision to defer fishmeal oil sales
in response to a softening of world protein markets. In addition, 1999 results
reflect increased or additional costs associated with operations of Zapata's
Internet properties. The first six months of 1998 results primarily reflected a
strong market for Omega Protein's fish oils and Zapata's gain on the sale of
Omega Protein stock.

OMEGA PROTEIN RESULTS OF OPERATIONS

FISCAL QUARTER ENDED JUNE 30, 1999

     REVENUES. Omega's revenues for the quarter ended June 30, 1999 decreased
     $13.3 million, or 42.2% from $31.5 million in the quarter ended June 30,
     1998. The decrease was attributable to lower sales volumes and lower sales
     prices for Omega's fish meal and fish oil. Sales volumes for fish meal and
     fish oil declined by 18.4% in the current quarter as compared to the
     quarter ended June 30, 1998. Fish meal sales and fish oil sales volumes for
     the current quarter decreased 22.3% and 9.6% respectively from the
     comparable prior year quarter ended June 30, 1998. Sales prices for fish
     meal and fish oil declined 21.2% and 45.3% respectively as compared to the
     prior year quarter ended June 30, 1998. The lower sales volumes for fish
     meal and fish oil is due to management's decision to defer sales during the
     current quarter as a result of lower prices. Omega attributes the decrease
     in selling prices to low cyclical feed costs affecting the protein
     industry.

         COST OF SALES. Omega's cost of sales, including depreciation and
     amortization for the quarter ended June 30, 1999 was $16.9 million, a $2.3
     million decrease from $19.2 million in the quarter ended June 30, 1998. The
     decrease in cost of sales was primarily due to an 18.4% decline in sales
     volumes of fish meal and fish oil in the current quarter as compared to the
     quarter ended June 30, 1998. Cost of sales as a percent of revenues was
     92.7% in the quarter ended June 30, 1999 as compared to 61.0% in the
     quarter ended June 30, 1998. The increase in cost of sales as a percent of
     revenues was due primarily to the decrease in the selling prices for fish
     meal and fish oil during the quarter ending June 30, 1998. Per ton cost of
     sales were 2.7% higher in the quarter ended June 30, 1999 as compared to
     the quarter ended June 30, 1998, due mainly to higher cost inventories
     carried forward from fiscal 1998. During August and September of 1998,
     fishing operations were hampered by a series of hurricanes and tropical
     storms that disrupted fishing operations, resulting in higher cost
     inventory.

         GROSS PROFIT. Gross Profit decreased $10.9 million or 89.3% from $12.3
     million in the quarter ended June 30, 1998 to $1.3 million in the quarter
     ended June 30, 1999. As a percentage of revenues, Omega's gross profit
     margin decreased 31.7% in the quarter ended June 30, 1999 compared to the
     same period in the prior fiscal year. The decline in gross


                                       19
<PAGE>   20
     profit was the result of both a decrease in revenues and higher cost of
     sales due to the higher cost of inventories carried forward from fiscal
     1998. This also resulted in a lower gross profit margin during the quarter
     ended June 30, 1999 compared to the quarter ended June 30, 1998.

         SELLING, GENERAL AND ADMINISTRATIVE EXPENSES. Selling, general and
     administrative expenses increased $391,000 or 20.5% from $1.9 million in
     the quarter ended June 30, 1998 compared to $2.3 million in the period
     ended June 30, 1999. The increase in expense was due primarily to increased
     personnel and marketing costs associated with Omega Protein's efforts to
     enter the U.S. food market with its refined menhaden oil, which is known
     as OmegaPure(TM).

         OPERATING INCOME. As a result of the factors discussed above, Omega's
     operating income decreased from $10.4 million in the quarter ended June 30,
     1998 to a loss of $1.0 million for the quarter ended June 30, 1999. As a
     percentage of revenue, operating income decreased from 32.9 % in the
     quarter ended June 30, 1998 to negative 5.3% in the period ended June 30,
     1999.

         INTEREST INCOME (EXPENSE), net. Interest income, net decreased by
     $156,000 in the quarter ended June 30, 1999 as compared to the previous
     quartered ended June 30, 1998. The decrease in net interest income was due
     to the reduction of cash and cash equivalents available for investment
     purposes during the quarter ended June 30, 1999 as compared to the previous
     quarter ended June 30, 1998.

         OTHER INCOME (EXPENSE), net. Other expense, net increased $69,000 in
     the quarter ended June 30, 1999 over the prior quarter ended June 30, 1998.
     During the previous quarter ended June 30, 1998, the Company experienced a
     gain on the sale of non-productive assets.

         PROVISION FOR INCOME TAXES. Omega recorded a $0.3 million provision for
     an income tax benefit for the quarter ended June 30, 1999. This represents
     an effective tax rate benefit of 36.0% on a $0.8 million loss in comparison
     to a $4.1 million tax provision in the quarter ended June 30, 1998,
     representing an effective tax rate of 37.2%. The effective tax rate
     approximates the applicable combined state and federal statutory tax rates
     for the fiscal year.

     SIX MONTHS ENDED JUNE 30, 1999

         REVENUES. For the six-months ended June 30, 1999 Omega Protein's
     revenues decreased $21.1 million, or 34.3% from $61.5 million in the
     quarter ended June 30, 1998. The decrease was attributable to lower sales
     volumes of fish meal and fish oil and lower prices for fish meal and fish
     oil. Sales volumes for fish meal and fish oil declined 13.3% and 24.6%
     respectively during the current six-month period ended June 30, 1999 as
     compared to the prior year six-month period ended June 30, 1998. Fish meal
     sales prices and fish oil prices declined 16.1% and 28.2% respectively as
     compared to the prior year six-month period ended June 30, 1998. The lower
     sales volumes for Omega Protein's fish meal and fish oil is due to
     management's decision to defer sales during the first six-month period
     ending June 30, 1999 as a result of lower market prices. Omega Protein
     attributes the decrease in selling prices to low cyclical feed cost
     affecting the


                                       20
<PAGE>   21
     protein industry.

         COST OF SALES. Omega Protein's cost of sales, including depreciation
     and amortization, for the six-months ended June 30, 1999 was $32.4
     million, a $4.3 million decrease from $36.7 million from the comparable
     six-month period ended June 30, 1998 primarily due to a 17.6% decline in
     sales volumes for fish meal and fish oil. As a percent of revenues, cost
     of sales was 80.2% in the six-month period ended June 30, 1999 as compared
     to 59.6% in the comparable six-month period ended June 30, 1998. The
     increase in cost of sales as a percent of revenues was due to decreases in
     selling prices for fish meal and fish oil of 16.1% and 28.2% respectively
     during the six-month period ended June 30, 1999. Per ton cost of sales
     were 5.6% higher in the six-month period ended June 30, 1999 as compared
     to the previous six-month ended June 30, 1998, due mainly to higher cost
     inventories carried forward from fiscal 1998. During August and September
     of 1998, fishing operations were hampered by a series of hurricanes and
     tropical storms that disrupted fishing operations, resulting in higher
     cost inventory.

         GROSS PROFIT. Gross Profit decreased $16.9 million or 67.9% from $24.9
     million in the six-month period ended June 30, 1998 to $8.0 million in the
     six-months ended June 30, 1999. As a percentage of revenues, Omega's gross
     profit margin decreased 20.6% in the six-month period ended June 30, 1999
     compared to the same six-month period in the prior fiscal year. The decline
     in gross profit was the result of a 16.1% and 28.2% decline in selling
     prices for fish meal and fish oil and a 5.6% higher cost of sales due to
     the higher cost of inventories carried forward from fiscal 1998, resulting
     in a lower gross profit margin during the first six-month period of fiscal
     1999 compared to the six-months ended June 30, 1998.

         SELLING, GENERAL AND ADMINISTRATIVE EXPENSES. Selling, general and
     administrative expenses increased $1.1 million or 32.4% from $3.4 million
     in the six-month period ended June 30, 1998 compared to $4.5 million in the
     period ended June 30, 1999. The increase in expense was due primarily to
     increased personnel and marketing costs associated with the Omega's efforts
     to enter the U.S. food market with its refined menhaden oil, along with
     increased costs associated with being a public company.

         OPERATING INCOME. As a result of the factors discussed above,
     Omega Protein's operating income decreased from $21.5 million in the
     six-months ended June 30, 1998 to $3.5 million for the period ended June
     30, 1999. As a percentage of revenue, operating income decreased from
     34.9% in the quarter ended June 30, 1998 to 8.7% in the period ended June
     30, 1999.

         INTEREST INCOME (EXPENSE), NET. Interest income, net increased by
     $833,000 from net interest expense in the six-month period ended June 30,
     1998 to net interest income during the current six-month period ended June
     30, 1999. The decrease in net interest expense was due to the Company's
     repayment of $33.3 million in intercompany loans to Zapata in April 1998
     with a portion of the proceeds from its initial public offering and the
     investment of the approximately $40.0 million in remaining net proceeds
     from the offering.

         OTHER INCOME (EXPENSE), NET. Other expense, net increased $91,000 in
     the six-month period ended June 30, 1999. During the previous six-months
     ended June 30, 1998, the


                                       21
<PAGE>   22
     Company experienced a gain on the sale of non-productive assets.

         PROVISION FOR INCOME TAXES. Omega recorded a $1.4 million provision for
     income tax expense for the six-month period ended June 30, 1999. This
     represents an effective tax rate of 36.0% in comparison to a $8.0 million
     tax provision in the quarter ended June 30, 1998, representing an effective
     tax rate of 38.0%. The effective tax rate approximates the applicable
     combined state and federal statutory tax rates for the fiscal year.

THE YEAR 2000

         The Year 2000 ("Y2K") issue is the result of computer programs using a
two-digit format, as opposed to four digits, to indicate the year. Some computer
systems will be unable to interpret dates beyond the year 1999, which could
cause a system failure or other computer errors leading to disruptions in
operations.

         Zapata has been in the process of acquiring its own hardware and
software systems for its business. Prior to any purchase of any hardware or
software, Zapata assesses the Y2K compatibility of a component through review of
the vendor documentation. In addition, to further ensure that Zapata's new
hardware and software is Y2K compliant, Zapata has contracted with an
independent third party to perform Y2K compliance testing of its entire
information technology system which is primarily comprised of the hardware and
software which it has purchased within the past six months. The test is expected
to be completed by the end of August at which time, Zapata will perform any
necessary actions required to ensure Y2K compliance. Zapata does not anticipate
that any such actions will have a material adverse affect on its operations. In
addition, Zapata does not anticipate that any material issues will arise with
respect to Omega Protein and the systems that Omega uses to provide
administrative support to Zapata.

         State of Readiness. The only software and hardware currently employed
by Zapata consist of a financial accounting package, off-the-shelf office
productivity software, and two servers associated with its Internet business,
all of which are Y2K complaint. The Company plans to assess the Y2K readiness of
any information technology ("IT") systems that it will be acquiring, including
the hardware and software that enable the Company to provide and deliver its
solutions, and its non-IT systems. Prior to purchasing any such hardware or
software, it will assess, with the help of consultants, whether such components
will properly recognize dates beyond December 31, 1999. The company does not
anticipate that any hardware or software that it will purchase or license will
have material problems in this regard as it will only purchase or license
current versions of hardware and software provided by major vendors. Moreover,
the Company plans to secure appropriate contractual assurances from its software
and hardware vendors that their software and hardware solutions are Y2K
compliant. Further, the Company plans to conduct a year 2000 simulation once the
Company's entire IT system and operating infrastructure is in place.

         Costs. To date, Zapata has incurred minimal expenditures in connection
with identifying or evaluating Y2K compliance issues. The Company expects to
incur operating costs associated with time spent by employees in the IT system
evaluation process and Y2K compliance matters


                                       22
<PAGE>   23
generally by its Internet subsidiary, ZAP.COM. However, Zapata does not expect
these future expenses to be material.

         Risks. Zapata is not currently aware of any Y2K compliance problems
relating to the IT or non-IT systems which it employs or plans to employ that
would have a material adverse effect on its business, prospects, results of
operations and financial condition. There can be no assurance that Zapata will
not discover Y2K compliance problems in hardware or software that it acquires
which will require substantial revisions or replacements, all of which could be
time consuming and expensive. The failure of Zapata to fix or replace third
party software, hardware, or services on a timely basis could result in lost
revenues, increased operating costs, the loss of customers and other business
interruptions, any of which could have a material adverse effect on Zapata
business, prospects, results of operations, and financial condition. Moreover,
the failure to adequately address Y2K compliance issues in its IT systems could
result in breaches of contract and related litigation, which could be costly
and time consuming to defend.

         In addition, there can be no assurance that governmental agencies,
utility companies, Internet access companies, third party service providers and
others outside Zapata's control will be Y2K compliant. The failure by such
entities to be Y2K compliant could result in a systemic failure beyond the
control of Zapata, such as a prolonged Internet, telecommunications or
electrical failure, which could also prevent Zapata or ZAP.COM from delivering
its services to its customers, decrease the use of the Internet or prevent users
from accessing the Web sites of its Web publisher customers, which could have a
material adverse effect on Zapata or ZAP.COM's business, prospects, results of
operations, and financial condition.

         Contingency Plan. Zapata has not yet developed any Y2K contingency
plans. The results of the independent third party Y2K testing will be taken into
account when determining the nature and extent of any contingency plans which it
develops.

         Zapata relies on the administrative support of Omega Protein, and
therefore, is reliant on Omega Protein to ensure its own Y2K compliance. Zapata
does not anticipate that any material issues will arise with respect to Omega
Protein in this regard before Zapata has developed its own systems so that it
may operate independently of Omega Protein. If Zapata becomes concerned that
Omega Protein is not Y2K compliant or has what Zapata believes to be inadequate
programs to become Y2K compliant prior to Zapata implementing its own computer
networking, financial and other systems, Zapata will accelerate its timetable
for moving to its own systems so as to reduce or eliminate its reliance on Omega
Protein.

         Omega Protein employs a number of IT systems, which are used by both
Omega Protein and Zapata including, without limitation, computer networking
systems, financial systems and other similar systems.

         Omega Protein has reported that it is aware of the issues surrounding
the Y2K and the problems that may occur. In 1997, Omega Protein developed a
program for Y2K compliance. Since 1997, Omega Protein has converted all of its
computer information systems to enable proper processing of critical management
information systems ("MIS") related to the Y2K issue


                                       23
<PAGE>   24
and beyond. Critical MIS systems consist of software programs such as the
operating system, spreadsheets, accounting and financial programs. Testing
methodology involved changing the date on the system being tested to be in the
year 2000 and then exercising all relevant applications to verify Y2K
compliance. Omega Protein's current estimates indicate that the costs of
addressing potential problems are not expected to have a material impact upon
Omega Protein's financial position, results of operations or cash flows in
future periods. To date, the cost of Omega Protein's Y2K Compliance program
(including, software conversion) has been immaterial.

         Omega Protein has reported that it continues to evaluate its
non-critical MIS systems and expects that they will be compliant prior to the
year 2000. Non-critical MIS systems refer to embedded technology such as micro
controllers found in computers and other hardware systems that Omega Protein has
identified as non-critical MIS systems. Non-critical MIS systems are those that
would not cause a disruption in any harvesting or manufacturing application
involved in producing product.

         Internal systems are not the only ones that may have a material effect
on Omega Protein. External relationships to Omega Protein such as vendors and
customers may also impact Omega Protein by their inability to deliver goods and
services required by Omega Protein to operate. Customers could impact Omega
Protein by their inability to operate, reducing the sale of product, or their
inability to pay Omega Protein for products purchased. Omega Protein has decided
to address this issue in fiscal 1999 by identifying major vendors and customers
and sending surveys to discover their level of Y2K compliance. Major vendors are
defined as those that provide critical goods or services to Omega Protein or
those that provide critical components to Omega Protein (such as fuel suppliers
and financial institutions). Major customers are identified as those customers
that are at the greatest risk of being impacted by the Y2K problem (mainly large
domestic and foreign industrial and commercial customers). The projected
completion date of system surveys of external parties is September 30, 1999.
There can be no guarantee that the systems of other companies on which Omega
Protein's systems rely will be timely converted or that a failure to convert by
another company or that a conversion that is incompatible with Omega Protein's
systems, would not have a material adverse affect on Omega Protein.

         At this point in time, Omega Protein has not engaged any firm, nor does
it plan to engage any firm, to perform an independent verification and
validation of its Y2K compliance.

         At present, Omega Protein does not have a contingency plan in place to
specifically cover the Y2K issues. However, Omega Protein's management continues
to evaluate its systems and expects that all of its systems will be compliant
prior to the year 2000.

         For a description of the Y2K issues faced by ZAP.COM with respect to
its business, see ZAP.COM's registration statement in form S-1 filed with the
Securities and Exchange Commission on April 13, 1999 under the captions "Risk
Factors-Year 2000 issues" and "Management Discussion and Analysis of Financial
Condition and Results of Operation-Year 2000."




                                       24
<PAGE>   25
PART II.  - OTHER INFORMATION


ITEM 1. LEGAL PROCEEDINGS

         On April 30, 1999, a state district court in Houston, Texas entered a
judgment against Zapata in a lawsuit brought by a former employee which was
commenced on April 1, 1998. The former employee alleged that he was entitled to
the value of options for approximately 240,000 shares of Zapata stock which he
alleges should have been issued to him in 1998 pursuant to his employment
agreement with Zapata. The judgment against Zapata was for approximately $3.45
million, which includes prejudgment interest. Zapata has posted a bond and
appealed the judgement. The Company continues to believe that it has a
meritorious defense to all or a substantial portion of the plaintiff's claim.
However, there can be no assurance that the Company will be successful in
appealing the judgment.




                                       25
<PAGE>   26
ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS



ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

          (a)  Exhibits:

               27.1 Financial Data Schedule

          (b)  Reports on Form 8-K:




                                       26
<PAGE>   27
                                   SIGNATURES

         Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.

                                                   ZAPATA CORPORATION
                                                      (Registrant)

August 12, 1999                                By: /s/ LEONARD DISALVO
                                                   -------------------
                                    (Vice President and Chief Financial Officer)



                                       27

<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                         136,939
<SECURITIES>                                         0
<RECEIVABLES>                                    7,741
<ALLOWANCES>                                       192
<INVENTORY>                                     59,271
<CURRENT-ASSETS>                               210,350
<PP&E>                                         137,403
<DEPRECIATION>                                  44,684
<TOTAL-ASSETS>                                 321,960
<CURRENT-LIABILITIES>                           23,071
<BONDS>                                         10,832
                                0
                                          0
<COMMON>                                           307
<OTHER-SE>                                     213,381
<TOTAL-LIABILITY-AND-EQUITY>                   321,960
<SALES>                                         18,225
<TOTAL-REVENUES>                                18,225
<CGS>                                           21,177
<TOTAL-COSTS>                                   21,177
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,412
<INCOME-PRETAX>                                (1,660)
<INCOME-TAX>                                     (564)
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                         0
<EPS-BASIC>                                     (0.04)
<EPS-DILUTED>                                   (0.04)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission